MedDataX Logo

Increased Rate of Prophylaxis Against Venous Thromboembolism Due to eAlerts

NCT ID: NCT01598805

Last Updated: 2012-11-16

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

10000 participants

Study Classification

INTERVENTIONAL

Study Start Date

2012-06-30

Study Completion Date

2012-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Now, after a cluster randomized controlled trial, eAlerts providing evidence-based guidelines on venous thromboembolism prophylaxis will be rolled out and evaluated hospital-widely.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

An eAlert is displayed in the electronic patient chart if no prophylaxis has been ordered within 6 h after admission or transfer. The eAlerts provide evidence-based guidelines on venous thromboembolism prophylaxis. Now, after a cluster randomized controlled trial, the eAlerts will be rolled out and evaluated hospital-widely.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Venous Thromboembolism

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

venous thromboembolism/prevention & control

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

roll out of eAlerts

Roll out of eAlerts providing evidence-based guidelines on prophylaxis against venous thromboembolism. An eAlert is displayed in the electronic patient chart if no prophylaxis has been ordered within 6 h after admission or transfer.

Group Type EXPERIMENTAL

electronic alerts

Intervention Type BEHAVIORAL

An eAlert is displayed in the electronic patient chart if no prophylaxis has been ordered within 6 h after admission or transfer.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

electronic alerts

An eAlert is displayed in the electronic patient chart if no prophylaxis has been ordered within 6 h after admission or transfer.

Intervention Type BEHAVIORAL

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

eAlert

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* all in-patients hospitalized in a ward with computerized physician order entry (CPOE),
* staying at least 24 h in a ward

Exclusion Criteria

* outpatients,
* ward without CPOE,
* patients transferred from an intervention to a control ward and vice versa
Minimum Eligible Age

16 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Zurich

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Juerg Blaser, Prof. PhD

Role: PRINCIPAL_INVESTIGATOR

University Hospital Zurich, Center for Clinical Research, Research Center for Medical Informatics

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University Hospital Zurich, Center for Clinical Research

Zurich, , Switzerland

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Switzerland

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

FZMI-KEK-ZH-Nr. 2010-0458

Identifier Type: -

Identifier Source: org_study_id